Improving Medication Management in World Trade Center Responders
ConditionPolypharmacy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.
Eligibility criteria
Qualifiers
A WTC responder already enrolled in the "Promoting Healthy Aging Among WTC Responders: Frailty Trajectories and Intervention Strategies" study cohort
aged 50 years or older, and
proton pump inhibitors (PPIs),
benzodiazepine (BZs) and
Disqualifiers
None
Trial design
Treatments tested in this trial
- Educational brochure for deprescribing
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov